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Other names: JAGGED1; HJ1; hJ1; JAGL1 
Location: 20p12.1-11.23 
Local order:  telomere PLCB1, PLCB4, PAK7, 




Table 1. Polymorphisms in the cDNA of JAG1. GenBank 
Accession no : HSU73936. 
Description 
The gene spans 36 kb on the short arm of chromosome  
20. It contains 26 exons (size from 28 bp to 2 kb) and 
25 introns (size from 89 bp to nearly 9 kb): table 1. 
Intron 19 contains a CA dinucleotide repeat which is a 
highly polymorphic marker: D20S1154 (12 alleles with 
heterozygosity of 85.8% and PIC of 0.844). 
Size of exons and introns of the human JAG1 gene  
exon 1: 494; intron 1: 443; exon 2: 306; intron 2: 8686; 
exon 3: 52; intron 3: 5240; exon 4: 255; intron 4: 2009; 
exon 5: 61; intron 5: 3799; exon 6: 131; intron 6: 217; 
exon 7: 120; intron 7: 436; exon 8: 114; intron 8: 1220; 
exon 9: 114; intron 9: 611; exon 10: 114; intron 10:
414; exon 11: 47; intron 11: 338; exon 12: 174; intro  
12: 438; exon 13: 151; intron 13: 856; exon 14: 165; 
intron 14: 854; exon 15: 114; intron 15: 501; exon 16:
114; intron 16: 99; exon 17: 114; intron 17: 163; exon 
18: 117; intron 18: 478; exon 19: 28; intron 19: 493; 
exon 20: 86; intron 20: 1176; exon 21: 114; intron 21:
595; exon 22: 110; intron 22: 89; exon 23: 234; intro  
23: 215; exon 24: 132; intron 24: 179; exon 25: 151; 
intron 25: 827; exon 26: 1979. 
Polymorphisms were described in the cDNA sequence 
(table 1). 
Transcription 
JAG1 is transcribed from centromere to telomere. The
26 exons are coding; exon 1 is coding on the last 81 
bases, and exon 26 on the first 455 bases. The transcript 
size is 5.5 kb. 
Protein 
Description 
Glycosylated transmembrane protein; 1218 amino 
acids. 
Predicted glycosylation sites: 960; 991; 1045; 1064. 
Apparent size on Western blot: about 180 kDa. 
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Figure 1. Schematic representation of the JAG1 protein (1218 amino acids). It contains signal peptide: SP (1-33), delta, serrate, lag-2 
domain: DSL (185-229), 16 EGF-like repeats (230-856; cf table 3), cysteine-rich region: CR (863-1002), transmembrane domain: TM 
(1068-1093), intracellular (cytoplasmic) part: IC (1094-1218). 
Table 2. EGF-like repeats of the human JAG1 protein. A : the 16 EGF motifs are aligned. A 24-amino acid insertion is present in EGF10 
(in grey, as in human JAG2 protein). The numbers above the sequences refer to cysteine residues (C in blue). Each EGF-like repeat 
contains 6 cysteine residues, able to make disulfide bond bridges: 1st with 3th ; 2nd with 4th and 5th with 6th. Some of these repeats are 
calcium-binding EGF-like domains, which have at their amino-terminus, negatively charged or polar residues such as aspartic acid (D), 
glutamic acid (E), glutamine (Q), and asparagine (N). B : consensus sequence of an EGF-like repeat. x is any amino acid. Three glycine 




Very wide; in heart, arteries, kidney, lung, pancreas, 
skeletal muscle, central nervous system, limb bud, etc. 
during embryonic and fetal development; in adult 
tissues; in tumors. 
Localisation 
Transmembrane plasma proteína. 
Function 
Ligand of the NOTCH family of receptors. The Notch 
signaling pathway plays a crucial role during 
embryonic pattern formation, controls many conserved 
cell determination events and defines a fundamental 
mechanism controlling cell fate. It is involved in 
lineage cell decisions in a variety of tissues. It plays a 
role in hematopoiesis, vascular development and 
angiogenesis, myogenesis, neurogenesis, 
somitogenesis; kidney, eye, ear, and tooth development 
etc. 
Homology 
Serrate in D. melanogaster; 
Lag-2 in C. elegans; 
Jagged 1a and jagged 1b in zebrafish (D. rerio); 
Jagged2 ou serrateB in zebrafish (D. rerio); 
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X-serrate-1 in tadpole (Xenopus laevis); 
C-serrate-1 and C-serrate-2 in chicken (Gallus gallus); 
Jagged1 and jagged2 in mouse (Mus musculus); 
Jagged1 and jagged2 in rat (Rattus norvegicus); 
Jagged1 and jagged2 in dog (Canis familiaris); 
Partial jagged1 in Bos Taurus; 
JAGGED2 in Homo sapiens. 
Mutations 
Note: Heterozygous mutations in JAG1 gene cause 
Alagille syndrome. 
Five per cent are deletions on the short arm of 
chromosome 20 that could be visible in cytogenetics: 
the whole gene or part of the gene, or a region larger 
than the gene can be deleted: del(20p), del(20)(p11.2), 
del(20)(p12.3-p11.23), del(20)(p13-p12.2), ins(7;20), 
t(2;20). 
Ninety five per cent are point intragenic mutations that 
are spread over the entire gene, with the exception of 
the part of the gene encoding the intracellular part of 
the protein (see the structure of the protein in Figure 2). 
Seventy per cent of mutations are nonsense or 
frameshift mutations leading to premature stop codons; 
15% are missense mutations and 14% are splice site  
mutations (Figure 3). The most frequent mutation 
(‘delCAGT’ in exon 17) accounts for 5% of all 
mutations. 
Some AGS probands present with no mutation in the 
DNA of the 26 exons and exon boundaries of JAG1. In 
those instances, no prenatal diagnosis can be 
performed. 
Germinal 
Most mutations (70%) are de novo. 
Somatic 
Cases of mosaicisms are described. 
Implicated in 
Alagille syndrome (AGS) 
Disease 
Syndrome associating 5 major features (complete 
syndrome): paucity of interlobular bile ducts, 
pulmonary artery stenosis, butterfly-like vertebrae, 
posterior embryotoxon and a peculiar face. Only the 2 
first ones are symptomatic. Incomplete syndrome is 
very frequent. AGS presents with a highly variable 
expressivity and nearly complete penetrance. 
 
 
Figure 3. Distribution of 344 intragenic JAG1 mutations in Alagille patients. We summarized all the mutations published so far and 
unpublished results from our laboratory and from A. Mantel (Hospital of Kremlin-Bicêtre). Seventy five per cent mutations (257/344) are 
different at the DNA level. Sequencing exons 2, 4, 6, 9, 17, 23, and 24 which correspond to 35% of cDNA, detect 53% of all mutations. 
The signal peptide is encoded by exon 1, and the DSL domain by part of exon 4, the 16 EGF-like repeats correspond to exons 5-21, the 
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Tetralogy of Fallot 
Disease 
The heterozygous mutation (G274D) in EGF2 of JAG1 
has been reported in one family: affected family 
members also had characteristic facies. 
Familial deafness, congenital heart 
defects, and posterior embryotoxon 
Disease 
The heterozygous mutation (C234Y) in EGF1 of JAG1 
has been reported in one family. 
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